中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (12): 1397-1400.DOI: 10.11852/zgetbjzz2024-1394
• 个案报道 • 上一篇
迪拉热依·达吾列提汉, 罗燕飞, 玛依拉·阿不都热依木, 米热古丽·买买提
收稿日期:2024-11-19
修回日期:2025-04-03
发布日期:2025-12-02
出版日期:2025-12-10
通讯作者:
米热古丽·买买提,E-mail:milikita17@aliyun.com
作者简介:迪拉热依·达吾列提汉(1999—),女,硕士学位,主要研究方向为儿童内分泌、遗传代谢病。
基金资助:Dilareyi·Dawulietihan1, Luo Yanfei1, Mayila·Abudureyimu1, Mireguli·Maimaiti1
Received:2024-11-19
Revised:2025-04-03
Online:2025-12-10
Published:2025-12-02
中图分类号:
迪拉热依·达吾列提汉, 罗燕飞, 玛依拉·阿不都热依木, 米热古丽·买买提. 自身免疫性多发内分泌腺病综合征1型1例[J]. 中国儿童保健杂志, 2025, 33(12): 1397-1400.
Dilareyi·Dawulietihan, Luo Yanfei, Mayila·Abudureyimu, Mireguli·Maimaiti. A case of autoimmune polyendocrine syndrome type 1[J]. Chinese Journal of Child Health Care, 2025, 33(12): 1397-1400.
| [1] Bruserud Ø, Oftedal BE, Landegren N, et al. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1[J]. J Clin Endocrinol Metab, 2016, 101(8):2975-2983. [2] Kahaly GJ, Frommer L. Autoimmune polyglandular diseases[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(6):101344. [3] Fierabracci A. Type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED): A "rare" manifestation in a "rare" disease[J]. Int J Mol Sci, 2016, 17(7):1106. [4] Wu H, Mo Y, Yu S, et al. Novel homozygous mutations in AIRE leading to APS-1 and potential mechanisms based on bioinformatics analysis[J]. Heliyon, 2024, 10(6):e28037. [5] 金雨, 杨涛. 自身免疫性多发性内分泌腺病综合征[J]. 内科急危重症杂志, 2015, 21(4):259-262. Jin Y, Yang T. Autoimmune multiple endocrinopathies syndrome[J]. Journal of Acute and Critical Medicine, 2015, 21(4):259-262.(in Chinese) [6] Brad GF, Nicoarǎ DM, Scutca AC, et al. Exploring chronic hypocalcemia: Insights into autoimmune polyglandular syndrome type 1—a case study and literature review[J]. J Clin Med, 2024, 13(8):2368. [7] Cutolo M. Autoimmune polyendocrine syndromes[J]. Autoimmun Rev, 2014, 13(2):85-89. [8] Philippot Q, Casanova J-L, Puel A. Candidiasis in patients with APS-1: Low IL-17, high IFN-γ, or both?[J]. Curr Opin Immunol, 2021, 72:318-323. [9] Guo C-J, Leung PSC, Zhang W, et al. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)[J]. Autoimmun Rev, 2018, 17(1):78-85. [10] Yukina M, Erofeeva T, Nurana N, et al. Novel gene mutations regulating immune responses in autoimmune polyglandular syndrome with an atypical course[J]. J Endocr Soc, 2021, 5(8):bvab077. [11] YHH ek E, Simsek T, Cilingir O. Early-onset chronic keratitis as the first presenting component of autoimmune polyendocrinopathy syndrome type 1 (APS-1): A case report and review of the literature[J]. J Clin Res Pediatr Endocrinol, 2023,17(3):359-364. [12] Stolarski B, Pronicka E, Korniszewski L, et al. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: Novel AIRE mutations and an estimate of disease prevalence[J]. Clin Genet, 2006, 70(4):348-354. [13] Fierabracci A, Lanzillotta M, Vorgučin I, et al. Report of two siblings with APECED in Serbia: Is there a founder effect of c.769C>T AIRE genotype?[J]. Ital J Pediatr, 2021, 47(1):126. [14] 孙永香,何亚非,栗夏连.1例自身免疫性多内分泌腺病综合征Ⅰ型患者的临床及家系AIRE基因突变分析[J].中国当代儿科杂志,2016,18(2):147-151. Sun YX, He YF, Li XL. Clinical and familial analysis of AIRE gene mutation in a patient with autoimmune polyendocrine syndrome type Ⅰ[J].Chin J Contemp Pediatr, 2016,18(2):147-151.(in Chinese) [15] Bjørklund G, Pivin M, Hangan T, et al. Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach[J]. Autoimmun Rev, 2022, 21(8):103135. [16] Radetti G, Puel A, Franceschi R, et al. A non-classical presentation of APECED in a family with heterozygous R203X AIRE gene mutation[J]. J Endocrinol Invest, 2022, 46(3):629-632. [17] Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy[J]. J Clin Immunol, 2015, 35(5):463-478. [18] 郑粼琳, 刘毅. 自身免疫多内分泌腺病综合征研究进展[J]. 临床误诊误治, 2019, 32(12):103-108. Zheng LL, Liu YI. Research progress of autoimmune polyendocrine syndrome[J]. Clinical misdiagnosis and mistreatment, 2019, 32(12):103-108. (in Chinese) [19] Tenório JR, Tuma MM, Andrade NS, et al. Oral manifestations of autoimmune polyglandular syndrome type 1[J]. Spec Care Dentist, 2022, 42(5):531-535. [20] Zhan F, Cao L. Late-onset autoimmune polyendocrine syndrome type 1: A case report and literature review[J]. Immunol Res, 2021, 69(2):139-144. [21] Belllo MO, Garla VV. Polyglandular autoimmune syndrome type Ⅰ[M]. Treasure Island(FL):StatPearls Publishing,2019. [22] Mezgueldi E, Bertholet-Thomas A, Milazzo S, et al. Early-onset hypoparathyroidism and chronic keratitis revealing APECED[J]. Clin Case Rep, 2015, 3(10):809-813. [23] 熊燕. 自身免疫性多内分泌腺病综合征一例[J]. 新医学, 2015, 46(4):268-272. Xiong Y. A case of autoimmune polyendocrine syndrome[J]. New Medicine, 2015, 46(4):268-272. (in Chinese) [24] Paldino G, Faienza MF, Cappa M, et al. Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies[J]. Front Immunol, 2023, 14:1172369. [25] Orlova EM, Sozaeva LS, Kareva MA, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1[J]. J Clin Endocrinol Metab, 2017, 102(9):3546-3556. [26] Mesbah Z, Tiwari N, Sacco K. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy-associated hepatitis[J]. ACG Case Rep J, 2023, 10(12):e01235. [27] Lévy R, Escudier A, Bastard P, et al. Ruxolitinib rescues multiorgan clinical autoimmunity in patients with APS-1[J]. J Clin Immunol 2023, 44(1):5. [28] Aytekin ES, Cagdas D. APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity[J]. Scand J Immunol, 2023, 98(2):e13299. [29] Husebye ES, Ingelfinger JR, Anderson MS, et al. Autoimmune polyendocrine syndromes[J]. N Engl J Med, 2018, 378(12):1132-1141. [30] Jacobson JD, Broussard JR, Marsh C, et al. Attenuation of autoimmune phenomena in a patient with autoimmune polyglandular syndrome type 1[J]. Case Rep Endocrinol, 2021, 2021:1-5. [31] Borchers J, Pukkala E, Mäkitie O, et al. Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections[J].J Clin Endocrinol Metab, 2020, 105(6):e2207-e2213. |
| [1] | 宋逸. 社会与自然环境暴露对青春期健康发展的影响与应对策略[J]. 中国儿童保健杂志, 2025, 33(12): 1281-1286. |
| [2] | 王依柔, 王秀敏. 矮身材合并基因变异的表型识别[J]. 中国儿童保健杂志, 2025, 33(12): 1287-1290. |
| [3] | 张宗翠, 马薇, 张红晓, 王玲, 刘金英, 马文元, 石蕊, 张羽. SPOCK、TMEM38B基因多态性与肃南地区女童月经初潮年龄的相关性研究[J]. 中国儿童保健杂志, 2025, 33(12): 1291-1297. |
| [4] | 陈熔, 蔡莹莹, 李沁瑜, 陈亮亮, 刘秀梅. 儿童抽动障碍共患注意缺陷多动障碍的影响因素及其联合作用研究[J]. 中国儿童保健杂志, 2025, 33(12): 1298-1302. |
| [5] | 华晶, 池霞, 宋骏, 芮洪新, 周建勇, 林枫. 儿童家庭玩具配置评估的项目反应理论模型[J]. 中国儿童保健杂志, 2025, 33(12): 1303-1309. |
| [6] | 王亚婷, 黄美欢, 崔瑞青, 周春明, 钟嘉敏, 贠国俊. 运动功能与计时测试对杜氏肌营养不良运动功能纵向变化的评估[J]. 中国儿童保健杂志, 2025, 33(12): 1310-1315. |
| [7] | 赖乾坤, 李银枝, 黄琦, 郭敬民, 姚清山. 巨细胞病毒感染与神经发育障碍之间的遗传预测因果效应分析[J]. 中国儿童保健杂志, 2025, 33(12): 1316-1322. |
| [8] | 陆林, 宋阳, 尹可丽, 任耕, 席莉莉. 父母共情与婴幼儿回应性照护的关系[J]. 中国儿童保健杂志, 2025, 33(12): 1323-1327. |
| [9] | 革婧婧, 王卫凯. 出生体重与0~6月龄儿童神经心理发育状况的关系研究[J]. 中国儿童保健杂志, 2025, 33(12): 1328-1332. |
| [10] | 侯耀奇, 雷宗翰, 王燕, 芦婉晶, 刘红, 宋湘勤. 发育性协调障碍儿童青少年运动干预的研究进展[J]. 中国儿童保健杂志, 2025, 33(12): 1333-1337. |
| [11] | 霍云凤, 吴娟娟, 王华. 妊娠期糖尿病对子代神经心理发育影响及机制研究进展[J]. 中国儿童保健杂志, 2025, 33(12): 1338-1342. |
| [12] | 钟嘉敏, 周春明, 黄美欢, 陈怡静, 王亚婷, 曹建国. 痉挛型脑瘫上肢选择性运动控制评估及干预研究进展[J]. 中国儿童保健杂志, 2025, 33(12): 1343-1347. |
| [13] | 支金草, 徐河, 常庆, 吴珊红, 秦欢, 王艳. 围产期抑郁对子代神经功能发育影响机制的研究进展[J]. 中国儿童保健杂志, 2025, 33(12): 1348-1352. |
| [14] | 郭红杰, 常万鹏, 刘帅, 黄艳. 不同全身振动参数对脑瘫儿童运动功能影响的研究进展[J]. 中国儿童保健杂志, 2025, 33(12): 1353-1357. |
| [15] | 房恩慧, 管惠, 田金鑫, 张浩, 马丽虹. 家庭干预治疗脑性瘫痪儿童疗效的Meta分析[J]. 中国儿童保健杂志, 2025, 33(12): 1358-1366. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||